Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.
Joseph DonovanNguyen D BangDarma ImranHo D T NghiaErlina BurhanDau T T HuongNguyen T T HiepLam H B NgocDang V ThanhNguyen T ThanhAnna L S WardhaniKartika MaharaniCakra P GasmaraNguyen H H HanhPham K N OanhRiwanti EstiasariDo D A ThuArdiana KusumaningrumLe T DungDo C GiangDang T M HaNguyen H LanNguyen V V ChauNguyen T M NguyetRonald B GeskusNguyen T T ThuongEvelyne KestelynRaph L HamersNguyen H PhuGuy E Thwaitesnull nullPublished in: The New England journal of medicine (2023)
Among HIV-positive adults with tuberculous meningitis, adjunctive dexamethasone, as compared with placebo, did not confer a benefit with respect to survival or any secondary end point. (Funded by the Wellcome Trust; ACT HIV ClinicalTrials.gov number, NCT03092817.).